News | January 14, 2025
Cube Biotech acquires IBA Lifesciences
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
This is used to treat central diabetes insipidus and bedwetting
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
ALS patients experience neuroinflammation and rapid neurodegeneration
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues
Subscribe To Our Newsletter & Stay Updated
